Back to results
TerminatedPhase 2

Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease

NCT00602680

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sanofi-Aventis Administrative Office

Paris, France

View on ClinicalTrials.gov
Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease — TrialFind